IP Library Granted Patent US 9,415,081
Granted Patent B2
US 9,415,081 · App. 13/803,963 · Granted Aug 16, 2016

Composition for preventing or treating AIDS containing plant stem cell line derived from cambium of Panax ginseng including wild ginseng or ginseng as active ingredient

Inventors: Sun Mi Hong (Jeonju-si, KR); Eun Kyong Lee (Iksan, KR); Young Woo Jin (Jeonju, KR)
Assignees: UNHWA CORPORATION; Young Woo Jin; Eun Kyounng Lee
A61K36/258A01H4/005A23L1/30A23L1/3002C12N5/04A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,415,081
App. No.
13/803,963
Granted
Aug 16, 2016
Kind
B2
Abstract

The present invention relates to a composition for preventing or treating acquired immunodeficiency syndrome (AIDS), comprising one or more of the following: a homogenous cell line, and a lysate, an extract and a culture thereof as an active ingredient. The homogenous cell line, the lysate, the extract and the culture thereof, which are derived from a natural product, minimize adverse side effects of prior therapeutic agents and safe for the human body. Further, they effectively increase the count of T cells such as CD4+ T cells and decrease the number of HIVs, thereby preventing opportunistic infection, dysneuria, and neoplaia caused by immune incompetence, and ultimately the risk of death. Therefore, they are useful in preventing and treating AIDS, and relieving symptoms of AIDS.

Claims (32)

1. A method of ameliorating acquired immunodeficiency syndrome (AIDS), the method comprising administering a cell line derived from the cambium of Panax ginseng , wherein the cell line has the following characteristics:

(a) it is in an innately undifferentiated state; and

(b) it is a homogeneous cell line.

2. The method of claim 1 , wherein the cell line further has the following characteristics:

(a) it is present as single cell level during a suspension culture;

(b) it has a lower sensitivity to shear stress in a bioreactor, compared to cell lines derived from tissues other than the cambium of Panax ginseng ; and

(c) its growth rate is higher than those of cell lines derived from tissues other than the cambium of Panax ginseng and is cultured stably.

3. The method of claim 1 , wherein the cell line is obtained by using an isolation method comprising the steps of:

(a) obtaining a Panax ginseng cambium-containing tissue;

(b) culturing the cambium-containing tissue in a medium supplemented with IAA (indole-3-acetic acid) or IBA (indole-3-butyric acid) to induce a cell line derived from the cambium, wherein an osmotic stress is applied to the cambium-containing tissue before, during, or after the culture; and

(c) collecting the induced, cambium-derived cell line.

4. The method of claim 3 , wherein step (c) is performed by proliferating the induced cambium-derived cell line in a medium which contains one or more of 2,4-D (2,4-dichlorophenoxyacetic acid), picloram and IBA, and then collecting the cambium-derived cells.

5. A method of ameliorating AIDS, the method comprising orally administering functional food comprising a cell line derived from the cambium of Panax ginseng , wherein the cell line has the following characteristics:

(a) it is in an innately undifferentiated state; and

(b) it is a homogeneous cell line.

6. The method of claim 5 , wherein the cell line further has the following characteristics:

(a) it is present as single cell level during a suspension culture;

(b) it has a lower sensitivity to shear stress in a bioreactor, compared to cell lines derived from tissues other than the cambium of Panax ginseng ; and

(c) its growth rate is higher than those of cell lines derived from tissues other than the cambium of Panax ginseng and is cultured stably.

7. The method of claim 5 , wherein the cell line is obtained by using an isolation method comprising the steps of:

(a) obtaining a Panax ginseng cambium-containing tissue;

(b) culturing the cambium-containing tissue in a medium supplemented with IAA or IBA to induce a cell line derived from the cambium, wherein an osmotic stress is applied to the cambium-containing tissue before, during, or after the culture; and

(c) collecting the induced, cambium-derived cell line.

8. The method of claim 7 , wherein step (c) is performed by proliferating the induced cambium-derived cell line in a medium which contains one or more of 2,4-D (2,4-dichlorophenoxyacetic acid), picloram and IBA, and then collecting the cambium-derived cells.

9. A method of increasing T cells, the method comprising administering a cell line, derived from the cambium of Panax ginseng , wherein the cell line and has the following characteristics:

(a) it is in an innately undifferentiated state; and

(b) it is a homogeneous cell line.

10. The method of claim 9 , wherein the cell line is obtained by using an isolation method comprising the steps of:

(a) obtaining a Panax ginseng cambium-containing tissue;

(b) culturing the cambium-containing tissue in a medium supplemented with IAA or IBA to induce a cell line derived from the cambium, wherein an osmotic stress is applied to the cambium-containing tissue before, during, or after the culture; and

(c) collecting the induced, cambium-derived cell line.

11. The method of claim 10 , wherein step (c) is performed by proliferating the induced cambium-derived cell line in a medium which contains one or more of 2,4-D (2,4-dichlorophenoxyacetic acid), picloram and IBA, and then collecting the cambium-derived cells.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 19, 2017
From: JIN, YOUNG WOO
To: WELLKEY HOLDINGS LIMITED
Reel/Frame 042436/0418 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 4, 2017
From: LEE, EUN KYONG
To: WELLKEY HOLDINGS LIMITED
Reel/Frame 042238/0102 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2016
From: UNHWA CORPORATION
To: WELLKEY HOLDINGS LIMITED
Reel/Frame 040174/0316 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2016
From: UNHWA CORPORATION
To: JIN, YOUNG WOO; LEE, EUN KYOUNG; UNHWA CORPORATION
Reel/Frame 039195/0464 →
Priority Claims (1)
KR 10-2008-0095877 · Sep 30, 2008 · national
Continuity (2)
Continuation 13121930
Related Publication 20140099285A1 · Apr 10, 2014